Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.62 |
| ▸ | LMNA | P02545 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2395370 | 0.84 | ALDH1A1 (0.66) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL11202055 | 0.84 | ALDH1A1 (0.73) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL17097394 | 0.83 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL6930563 | 0.81 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL3485204 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL8094638 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL6930554 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL27438319 | 0.80 | ALDH1A1 (0.57) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL10721861 | 0.79 | ALDH1A1 (0.55) | ALDH1A1LMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL13542039 | 0.78 | ALDH1A1 (0.58) | ALDH1A1LMNATSHRSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100021480-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2010-01-28 | — | — | US | claimed |
| EP-1948676-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | Peptron Co., Ltd. (KR) | 2008-07-30 | — | — | EP | claimed |
| WO-2007049940-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | claimed |
| WO-2007049941-A1 | BIOACTIVE SUBSTANCE CARRIER FOR IN VIVO STABLE DELIVERY TEHREOF, CONJUGATE CONTAINING THE SAME, AND METHOD OF IN VIVO STABLE DELIVERY OF THE BIOACTIVE SUBSTANCE | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | claimed |
| US-20100021480-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2010-01-28 | — | — | US | disclosed |
| EP-1948676-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | Peptron Co., Ltd. (KR) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007049941-A1 | BIOACTIVE SUBSTANCE CARRIER FOR IN VIVO STABLE DELIVERY TEHREOF, CONJUGATE CONTAINING THE SAME, AND METHOD OF IN VIVO STABLE DELIVERY OF THE BIOACTIVE SUBSTANCE | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | disclosed |
| WO-2007049940-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | PEPTRON CO., LTD (KR) | 2007-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100021480-A1 | BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME | SERPINA6, CSTB, PLG | ALDH1A1 1756/4885LMNA 1097/4885TSHR 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.